Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7297526 Human DNase

Patent 7297526 was granted and assigned to Genentech on November, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Steven Shak0

Date of Patent

November 20, 2007

0

Patent Application Number

108390460

Date Filed

May 4, 2004

0

Patent Citations Received

US Patent 11667890 Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion

0

US Patent 11993792 DNase I variants, compositions, methods, and kits

0

US Patent 11701410 Extracellular DNA as a therapeutic target in neurodegeneration

0

US Patent 11905522 Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activity

0

Patent Primary Examiner

Tekchand Saidha

0

Patent abstract

DNA isolates coding for human DNase and methods of obtaining such DNA are provided, together with expression systems for recombinant production of human DNase useful in therapeutic or diagnostic compositions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7297526 Human DNase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.